Literature DB >> 27858286

Hypoxic Preconditioning Augments the Therapeutic Efficacy of Bone Marrow Stromal Cells in a Rat Ischemic Stroke Model.

Jin Chen1, Yuanyuan Yang2,3, Lihua Shen4, Wensen Ding1, Xiang Chen1, Erbing Wu1, Kefu Cai1, Guohua Wang5,6.   

Abstract

Transplantation of bone marrow stromal cells (BMSCs) is a promising therapy for ischemic stroke, but the poor oxygen environment in brain lesions limits the efficacy of cell-based therapies. Here, we tested whether hypoxic preconditioning (HP) could augment the efficacy of BMSC transplantation in a rat ischemic stroke model and investigated the underlying mechanism of the effect of HP. In vitro, BMSCs were divided into five passage (P0, P1, P2, P3, and P4) groups, and HP was applied to the groups by incubating the cells with 1% oxygen for 0, 4, 8, 12, and 24 h, respectively. We demonstrated that the expression of hypoxia-inducible factor-1α (HIF-1α) was increased in the HP-treated BMSCs, while their viability was unchanged. We also found that HP decreased the apoptosis of BMSCs during subsequent simulated ischemia-reperfusion (I/R) injury, especially in the 8-h HP group. In vivo, a rat transient focal cerebral ischemia model was established. These rats were administered normal cultured BMSCs (N-BMSCs), HP-treated BMSCs (H-BMSCs), or DMEM cell culture medium (control) at 24 h after the ischemic insult. Compared with the DMEM control group, the two BMSC-transplanted groups exhibited significantly improved functional recovery and reduced infarct volume, especially the H-BMSC group. Moreover, HP decreased neuronal apoptosis and enhanced the expression of BDNF and VEGF in the ischemic brain. Survival and differentiation of transplanted BMSCs were also increased by HP, and the quantity of engrafted BMSCs was significantly correlated with neurological function improvement. These results suggest that HP may enhance the therapeutic efficacy of BMSCs in an ischemic stroke model. The underlying mechanism likely involves the inhibition of caspase-3 activation and an increasing expression of HIF-1α, which promotes angiogenesis and neurogenesis and thereby reduces neuronal death and improves neurological function.

Entities:  

Keywords:  Angiogenesis; Bone marrow stromal cells (BMSCs); Hypoxic preconditioning (HP); Ischemic stroke; Neurogenesis

Mesh:

Substances:

Year:  2016        PMID: 27858286     DOI: 10.1007/s10571-016-0445-1

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  55 in total

1.  Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells.

Authors:  Simi M Chacko; Shabnam Ahmed; Karuppaiyah Selvendiran; M Lakshmi Kuppusamy; Mahmood Khan; Periannan Kuppusamy
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

2.  Corticosteroid responses following hypoxic preconditioning provide neuroprotection against subsequent hypoxic-ischemic brain injury in the newborn rats.

Authors:  Yangzheng Feng; Abhay J Bhatt
Journal:  Int J Dev Neurosci       Date:  2015-04-30       Impact factor: 2.457

3.  Allogeneic bone marrow stromal cell transplantation after cerebral hemorrhage achieves cell transdifferentiation and modulates endogenous neurogenesis.

Authors:  Laura Otero; Mercedes Zurita; Celia Bonilla; Concepción Aguayo; Miguel A Rico; Alicia Rodríguez; Jesús Vaquero
Journal:  Cytotherapy       Date:  2011-09-23       Impact factor: 5.414

4.  Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice.

Authors:  Jinmei Sun; Zheng Zachory Wei; Xiaohuan Gu; James Ya Zhang; Yongbo Zhang; Jimei Li; Ling Wei
Journal:  Exp Neurol       Date:  2015-03-20       Impact factor: 5.330

Review 5.  Ischemia-reperfusion injury: beneficial effects of mesenchymal stromal cells.

Authors:  Naima Souidi; Meaghan Stolk; Martina Seifert
Journal:  Curr Opin Organ Transplant       Date:  2013-02       Impact factor: 2.640

6.  SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model.

Authors:  Ye Wang; Yubin Deng; Guang-Qian Zhou
Journal:  Brain Res       Date:  2007-12-14       Impact factor: 3.252

7.  Differential recovery of multimodal MRI and behavior after transient focal cerebral ischemia in rats.

Authors:  Kenneth M Sicard; Nils Henninger; Marc Fisher; Timothy Q Duong; Craig F Ferris
Journal:  J Cereb Blood Flow Metab       Date:  2006-03-15       Impact factor: 6.200

Review 8.  Potential of adult neural stem cells in stroke therapy.

Authors:  Robert H Andres; Raymond Choi; Gary K Steinberg; Raphael Guzman
Journal:  Regen Med       Date:  2008-11       Impact factor: 3.806

9.  SDF-1α/CXCR4 Axis Mediates The Migration of Mesenchymal Stem Cells to The Hypoxic-Ischemic Brain Lesion in A Rat Model.

Authors:  Qin Yu; Lizhen Liu; Jie Lin; Yan Wang; Xiaobo Xuan; Ying Guo; Shaojun Hu
Journal:  Cell J       Date:  2015-01-13       Impact factor: 2.479

10.  Circulating endothelial progenitor cells in cerebrovascular disease.

Authors:  Keun-Hwa Jung; Jae-Kyu Roh
Journal:  J Clin Neurol       Date:  2008-12-31       Impact factor: 3.077

View more
  18 in total

1.  Hypoxic Preconditioning Enhances the Efficacy of Mesenchymal Stem Cells-Derived Conditioned Medium in Switching Microglia toward Anti-inflammatory Polarization in Ischemia/Reperfusion.

Authors:  Han Yu; Zhihong Xu; Gaojing Qu; Huimin Wang; Lulu Lin; Xianyu Li; Xiaolin Xie; Yifeng Lei; Xiaohua He; Yun Chen; Yinping Li
Journal:  Cell Mol Neurobiol       Date:  2020-05-18       Impact factor: 5.046

Review 2.  Stem Cell Therapies for Restorative Treatments of Central Nervous System Ischemia-Reperfusion Injury.

Authors:  Ge Li; Ping Zhu; Qi-Song Su; Dong-Lin Zhuang; Moussa Ide Nasser; Xiyalatu Sai; Gang Deng
Journal:  Cell Mol Neurobiol       Date:  2022-02-07       Impact factor: 5.046

3.  NGF/TrkA promotes the vitality, migration and adhesion of bone marrow stromal cells in hypoxia by regulating the Nrf2 pathway.

Authors:  Cui-Ni Fang; Hai-Qun Tan; Ao-Bo Song; Ni Jiang; Qian-Rong Liu; Tao Song
Journal:  Metab Brain Dis       Date:  2022-05-17       Impact factor: 3.655

Review 4.  Preconditioning Methods to Improve Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Bone Regeneration-A Systematic Review.

Authors:  Fernanda Campos Hertel; Aline Silvestrini da Silva; Adriano de Paula Sabino; Fabrício Luciani Valente; Emily Correna Carlo Reis
Journal:  Biology (Basel)       Date:  2022-05-11

5.  Transplantation of Hypoxic-Preconditioned Bone Mesenchymal Stem Cells Retards Intervertebral Disc Degeneration via Enhancing Implanted Cell Survival and Migration in Rats.

Authors:  Weiheng Wang; Yang Wang; Guoying Deng; Jun Ma; Xiaodong Huang; Jiangming Yu; Yanhai Xi; Xiaojian Ye
Journal:  Stem Cells Int       Date:  2018-02-14       Impact factor: 5.443

6.  Effects of the Insulted Neuronal Cells-Derived Extracellular Vesicles on the Survival of Umbilical Cord-Derived Mesenchymal Stem Cells following Cerebral Ischemia/Reperfusion Injury.

Authors:  Yan Huang; Zuo Liu; Fengbo Tan; Zhiping Hu; Ming Lu
Journal:  Oxid Med Cell Longev       Date:  2020-07-16       Impact factor: 6.543

Review 7.  Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke.

Authors:  Yinghan Guo; Yucong Peng; Hanhai Zeng; Gao Chen
Journal:  Stem Cells Int       Date:  2021-06-15       Impact factor: 5.443

8.  Biomimicry in mending the broken heart; Will hypoxia and pulsatile flow play Cupids?

Authors: 
Journal:  J Stem Cells Regen Med       Date:  2017-12-18

Review 9.  Neuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases.

Authors:  Jia Liu; Yakun Gu; Mengyuan Guo; Xunming Ji
Journal:  CNS Neurosci Ther       Date:  2021-08       Impact factor: 5.243

10.  Hypoxic preconditioning rejuvenates mesenchymal stem cells and enhances neuroprotection following intracerebral hemorrhage via the miR-326-mediated autophagy.

Authors:  Jianyang Liu; Jialin He; Lite Ge; Han Xiao; Yan Huang; Liuwang Zeng; Zheng Jiang; Ming Lu; Zhiping Hu
Journal:  Stem Cell Res Ther       Date:  2021-07-22       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.